Articles by William F. Koch - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by William F. Koch

Inside USP: USP Reaches 2500 Reference Standards

Collaboration has been key to the pharmacopeia's achievement.
Apr 2, 2010

Collaboration has been key to the pharmacopeia's achievement.

Inside USP: Heparin Monographs Further Revised

USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.
Mar 2, 2009

USP's Stage 2 heparin monograph revisions address identification, potency, and impurities.

Inside USP: USP Metals Testing: A Workshop Report

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Nov 2, 2008

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

Inside USP: Metrology and USP Dissolution

The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure.
Mar 2, 2008

The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here